Señales en vivo de 008930.KS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 abr 2024 @ 02:30):

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer...

Stats
Volumen de hoy	129 742
Volumen promedio	393 160
Capitalización de mercado	2 303.96B
EPS	KRW0 ( 2024-04-23 )
Próxima fecha de ganancias	( KRW0 ) 2024-05-03
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW69.63 (0.20%)

Volumen Correlación

Largo: -0.04 (neutral)

Corto: 0.79 (moderate)

Signal:(55.691) Neutral

Hanmi Science Co., Ltd. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hanmi Science Co., Ltd. Correlación - Moneda/Commodity

-0.80
( strong negative )

-0.79
( moderate negative )

0.16
( neutral )

0.25
( neutral )

0.71
( moderate )

Hanmi Science Co., Ltd. Finanzas

Annual	2023
Ingresos:	KRW1 247.91B
Beneficio Bruto:	KRW226.86B (18.18 %)
EPS:	KRW1 694.06

FY	2023
Ingresos:	KRW1 247.91B
Beneficio Bruto:	KRW226.86B (18.18 %)
EPS:	KRW1 694.06

FY	2022
Ingresos:	KRW1 046.05B
Beneficio Bruto:	KRW101.70B (9.72 %)
EPS:	KRW1 010.45

FY	2021
Ingresos:	KRW950.16B
Beneficio Bruto:	KRW132.77B (13.97 %)
EPS:	KRW650.96

Financial Reports:

No articles found.

Hanmi Science Co., Ltd.

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer. The company also offers drug substances, general medicines, health functional foods, and nutrition and health products and services. In addition, it operates an online pharmacy; and offers pharmaceutical management automation systems. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is based in Seoul, South Korea.

Actualizaciones en tiempo real para Hanmi Science Co., Ltd. [008930.KS]

Upcoming Earnings Alert